GFS
GLOBALFOUNDRIES (GFS) Expands Marvell Deal for SiGe Optical Chip Capacity
GlobalFoundries and Marvell signed a multi-year agreement to expand silicon germanium capacity in Vermont for next-generation optical connectivity in AI data centers.
GFS
GlobalFoundries and Marvell signed a multi-year agreement to expand silicon germanium capacity in Vermont for next-generation optical connectivity in AI data centers.
WIMI
WiMi Hologram Cloud reported a first-half net loss of RMB 190.1 million as advertising revenue fell 27.3% and short-term investments turned sharply negative.
ADPT
Updated NCCN myeloma guidelines add a dedicated MRD testing page and name clonoSEQ as the only assay specifically cited, with 10-6 sensitivity preferred.
DHT
A Form 4 shows DHT Holdings director Erik Lind sold 30,000 shares at $22.46 apiece on September 15, leaving him with 132,294 shares.
CLSK
An investor presentation confirms a 20-year triple-net lease worth about $6.6 billion, guaranteed by Meta, with rent starting late 2027.
LAB
Labrador Gold plans a non-brokered private placement of up to $4 million at $0.05 per share and will appoint Raymond D. Harari as President and director.
AQST
Aquestive Therapeutics has refiled its New Drug Application for Anaphylm sublingual epinephrine film after completing the human factors and PK studies the FDA demanded.
AQST
Aquestive has refiled its application for the needle-free epinephrine film Anaphylm, backed by new human factors and pharmacokinetic data.
PBYI
Two Puma Biotechnology directors sold a combined 67,150 shares on 14 September at around $9.10 apiece, one of them right after exercising options.
CHRN
An amendment pushes the maturity of a $2 million secured note to November 12, 2026 and makes a sale of the Ekso Bionics unit a permitted disposition.
UMC
Liu Chitung disposed of 1.6 million UMC shares on the open market over two days, leaving a holding of about 2.64 million shares.
WOLF
Pro forma filing shows $1.3 billion of new secured notes, roughly 43.6 million new shares and a $10 million escrow gain after regulatory clearances landed.